Serum fetuin-A and arginase-1 in human obesity model: Is there any interaction between inflammatory status and arginine metabolism?

References

• Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, Chamari M. Is obesity associated with increased plasma lipid peroxidation and oxidative stress in women. ARYA Atheroscler J 2007;2:189–92.
   Google Scholar
• Sikaris K. The clinical biochemistry of obesity. Clin Biochem Rev 2004;25:165–181.
   PubMedGoogle Scholar
• Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007;262:408–14.
   PubMed Web of Science ®Google Scholar
• Hevener AL, Febbraio MA. The 2009 stock conference report: inflammation, obesity and metabolic disease. Obes Rev 2010;11:635–44.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7.
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347–55.
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129–39.
   PubMed Web of Science ®Google Scholar
• Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinic biochemical perspective. Angiology 2007;58:513–22.
   PubMed Web of Science ®Google Scholar
• Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH. Urinary 8-iso-Prostaglandin F2α as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004;109:843–8
   PubMed Web of Science ®Google Scholar
• Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008;659:15–30.
   PubMed Web of Science ®Google Scholar
• Holvoet P, De Keyzer D, Jacobs DR. Oxidized LDL and the metabolic syndrome. Future Lipidol 2008;3:637–49.
   PubMed Web of Science ®Google Scholar
• Mori K, Emoto M, Inaba M. Fetuin-A: a multifunctional protein. Recent Pat Endocr Metab Immune Drug Discov 2011;5:124–46.
   PubMedGoogle Scholar
• Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853–7.
   PubMed Web of Science ®Google Scholar
• Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Haring HU, Stefan N. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 2008;3:e1765.
   PubMed Web of Science ®Google Scholar
• Agote Robertson M, Finochietto P, Gamba CA, Dagrosa MA, Viaggi ME, Franco MC, Poderoso JJ, Juvenal GJ, Pisarev MA. Nicotinamide increases thyroid radiosensitivity by stimulating nitric oxide synthase expression and the generation of organic peroxides. Horm Metab Res 2006;38:12–5.
   PubMed Web of Science ®Google Scholar
• Tentolouris C, Tousoulis D, Goumas G, Stefanadis C, Davies G, Toutouzas P. L-Arginine in coronary atherosclerosis. Int J Cardiol 2000;75:123–8.
   PubMed Web of Science ®Google Scholar
• Tousoulis D, Antoniades C, Tentolouris C, Goumas G, Stefanadis C, Toutouzas P. L-arginine in cardiovascular disease: dream or reality?. Vasc Med 2002;7:203–11.
   PubMed Web of Science ®Google Scholar
• Reid KM, Tsung A, Kaizu T, Jeyabalan G, Ikeda A, Shao L, Wu G, Murase N, Geller DA. Liver I/R injury is improved by the arginase inhibitor, N-ω-Hydroxy-Nor-L-arginine (Nor-NOHA). Am J Physiol Gastrointest Liver Physiol 2007;292:512–7.
   PubMed Web of Science ®Google Scholar
• Kim OY, Lee SM, Chung JH, Do HJ, Moon J, Shin MJ. Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity. Nutrition 2012:28:635–9.
   PubMed Web of Science ®Google Scholar
• Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 2006;113:1760–7.
   PubMed Web of Science ®Google Scholar
• Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG. Health ABC Study, fetuin-A and incident diabetes mellitus in older persons. JAMA 2008;300:182–8.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;7:412–9.
   Web of Science ®Google Scholar
• Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, Xiao X, Shan ZL, Zhang Y, Yao P, Liu LG. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2013;36:166–75.
   PubMed Web of Science ®Google Scholar
• Tokuda F, Sando Y, Matsui H, Yokoyama T. N epsilon-(hexanoyl) lysine, a new oxidative stress marker is increased in metabolic syndrome, but not in obstructive sleep apnea. Am J Med Sci 2009;338:127–33.
   PubMed Web of Science ®Google Scholar
• Engeli S, Tsikas D, Lehmann AC, Böhnke J, Haas V, Strauß A, Janke J, Gorzelniak K, Luft FC, Jordan J. Influence of dietary fat ingestion on asymmetrical dimethylarginine in lean and obese human subjects. Nutr Metab Cardiovasc Dis 2012;22:720–26.
   PubMed Web of Science ®Google Scholar
• Dogru T, Genc H, Tapan S, Aslan F, Ercin CN, Ors F, Kara M, Sertoglu E, Karslioglu Y, Bagci S, Kurt I, Sonmez A. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 2013;78:712–7.
   PubMed Web of Science ®Google Scholar
• Jung C, Figulla HR, Lichtenauer M, Franz M, Pernow J. Increased levels of circulating arginase I in overweight compared to normal weight adolescents. Pediatr Diabetes 2014;15:51–66.
   PubMed Web of Science ®Google Scholar
• Öner-İyidoğan Y, Koçak H, Seyidhanoğlu M, Gürdöl F, Gülçubuk A, Yildirim F, Çevik A, Uysal M. Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. J Physiol Biochem 2013;69:677–86.
   PubMed Web of Science ®Google Scholar
• Ix JH, Sharma K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol 2010;21:406–12.
   PubMed Web of Science ®Google Scholar
• Goustin AS, Abou-Samra AB. The ‘thrifty’ gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal 2011;23:980–90.
   PubMed Web of Science ®Google Scholar
• Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, Haaland T, Konopski Z, Wium C, Aasheim ET, Johansen OE, Aukrust P, Halvorsen B, Birkeland KI. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 2012;166:503–10.
   PubMed Web of Science ®Google Scholar
• Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013;9:144–52.
   PubMed Web of Science ®Google Scholar
• Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol 2000;164:87–98.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab 2006;91:1896–900.
   PubMed Web of Science ®Google Scholar
• Palomo I, Contreras A, Alarcón LM, Leiva E, Guzmán L, Mujica V, Icaza G, Díaz N, González DR, Moore-Carrasco R. Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide 2011;24:224–8.
   PubMed Web of Science ®Google Scholar
• Garcia RG, Perez M, Maas R, Schwedhelm E, Böger RH, López-Jaramillo P. Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome. Int J Cardiol 2007;122:176–8.
   PubMed Web of Science ®Google Scholar
• Murayama H, Ikemoto M, Fukuda Y, Tsunekawa S, Nagata A. Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats. Clin Chim Acta 2007;375:63–8.
   PubMed Web of Science ®Google Scholar
• Moon J, Do HJ, Cho Y, Shin MJ. Arginase inhibition ameliorates hepatic metabolic abnormalities in obese mice. PLoS One 2014;9:e103048.
   PubMedGoogle Scholar
• Sriwijitkamol A, Coletta DK, Wajcberg E, Balbontin GB, Reyna SM, Barrientes J, Eagan PA, Jenkinson CP, Cersosimo E, DeFronzo RA, Sakamoto K, Musi N. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes 2007;56:836–48.
   PubMed Web of Science ®Google Scholar
• Brix JM, Stingl H, Höllerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab 2010;95:4877–81.
   PubMed Web of Science ®Google Scholar